What are the microscopic findings in hemangioma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Microscopic Findings in Hemangioma

Hemangiomas display dramatically different histologic features depending on their phase of evolution, with early proliferative lesions showing well-defined masses of capillaries lined by plump endothelial cells with numerous mitotic figures, while involuting lesions demonstrate thick, hyalinized basement membranes with apoptotic debris and eventual replacement by fibro-fatty stroma. 1

Early Proliferative Phase Histology

The proliferative phase is characterized by well-circumscribed, unencapsulated masses of capillaries arranged in lobules, separated by delicate fibrous septae. 1

Key microscopic features include:

  • Plump endothelial cells with variably enlarged nuclei and abundant clear cytoplasm lining the capillaries 1
  • Plump pericytes embedded within a multilaminated basement membrane without associated smooth muscle cells 1
  • Numerous normally configured mitotic figures, with widespread expression of cell proliferation markers such as Ki-67 confirming active division of both pericytes and endothelial cells 1
  • Lobular arrangement of proliferating capillaries that intermingle nondestructively with surrounding tissues including skeletal muscle fibers, peripheral nerves, salivary glands, and adipocytes 1
  • Enlarged draining veins with thick, asymmetric walls due to the high-flow nature of proliferative hemangiomas 1

Involuting Phase Histology

As involution proceeds, mitotic figures wane and apoptotic bodies increase, with lesional capillaries progressively disappearing without evidence of thrombosis or prominent inflammation. 1

Characteristic involutional features include:

  • Thick and hyalinized capillary basement membranes containing specks of apoptotic debris 1
  • Increased mast cells during early involution 1
  • Progressive disappearance of lesional capillaries through apoptosis rather than thrombosis 1
  • "Ghost vessels" composed of residual, thickened rinds of basement membrane material containing apoptotic debris without intact endothelial cells 1
  • End-stage replacement with loose fibrous or fibro-fatty stroma 1

Immunohistochemical Markers

GLUT1 (glucose transporter-1) immunopositivity is the definitive marker for infantile hemangiomas, distinguishing them from vascular malformations which are GLUT1-negative. 1

  • GLUT1 remains positive in residual lesion-type capillaries even during involution, making it useful for confirming diagnosis when histologic features are ambiguous 1

Important Diagnostic Considerations

There is no sharp dividing line between proliferation and involution, and features of both phases typically coexist during much of the natural history. 1

Critical pitfalls to avoid:

  • Early proliferative hemangiomas may focally resemble pyogenic granulomas due to their rapidly growing vascular proliferations 1
  • Interpretation requires proper clinical context including patient age and lesion behavior, as histologic features change dramatically throughout the natural course 1
  • Grossly, proliferative and early involutive lesions appear as well-circumscribed masses with red-to-tan cut surfaces, while later involutive lesions become fibro-fatty and less defined 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.